RS3PE syndrome presenting as vascular endothelial growth factor associated disorder

Annals of the Rheumatic Diseases

Volumn 64, Issue 11, 2005, Pages 1653-1655

  Arima, K ^a   Origuchi, T ^a   Tamai, M ^a   Iwanaga, N ^a   Izumi, Y ^a   Huang, M ^a   Tanaka, F ^a   Kamachi, M ^a   Aratake, K ^a   Nakamura, H ^a   Ida, H ^a   Uetani, M ^a   Kawakami, A ^a   Eguchi, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RS3PE SYNDROME; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADRENAL CORTEX HORMONES; EDEMA; HUMANS; INTERLEUKIN-1; MAGNETIC RESONANCE IMAGING; SUBCUTANEOUS TISSUE; SYNDROME; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27444446802     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.032995     Document Type: Article

References (15)

1. McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 1985;254:2763-7.
2. Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol 1999;26:115-20.
3. Tunc SE, Arslan C, Ayvacioglu NB, Sahin M, Akkus S, Yorgancigil H. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): a report of two cases and review of the literature. Rheumatol Int 2004;24:234-7.
4. Oide T, Ohara S, Oguchi K, Maruyama M, Yazawa M, Inoue K, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in Nagano, Japan: clinical, radiological, and cytokine studies of 13 patients. Clin Exp Rheumatol 2004;22:91-8.
5. Matsuda M, Sakurai K, Fushimi T, Yamamoto K, Rokuhara S, Hosaka N, et al. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities. Clin Rheumatol 2004;23:246-8.
6. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002;39:225-37.
7. Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, et al. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 2003;132:158-62.
8. Robak E, Wozniacka A, Sysa-Jedrzeiowska A, Stepien H, Robak T. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Lupus 2002;11:348-55.
9. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-93.
10. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet 1996;348:370-4.
11. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
12. Yamauchi A, Ito Y, Morikawa M, Kobune M, Huang J, Sasaki K, et al. Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 2003;5:994-1004.
13. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
14. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, et al. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 2002;61:804-9.
15. Hashiguchi T, Arimura K, Matsumuro K, Otsuka R, Watanabe O, Jonosono M, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000;23:1051-6.